MEDTEQ Consortium for Industrial Research and Innovation in Medical Technology MEDTEQ is the Consortium for Industrial Research and Innovation in Medical Technology. Its mission is to accelerate the development of technological solutions to improve patients’ health and quality of life. MEDTEQ supports their validation and integration in the healthcare system and their impact, both locally and globally, by bringing together the complementary skills of industrial and academic partners with those of healthcare providers.
Time-to-market & product adoption are a pain-point for health-tech innovators 1. R&D & regulatory are multi-stakeholder activities 2. Reimbursement & sales balance competing interests 3. Complex decision-making pathways 4. Capital intensive 5. Access to new markets needs local champions
Collaborative innovation and commercialization How does it work ? AT LEAST 2 PRIVATE PARTNERS AT LEAST 1 COMPANY (INCLUDING 1 IN QC) IN QC 20% FEDERAL FEDERAL 1 COMPANY 40% 40% 40% 40% (HBHL, MITACS…) (HBHL,, MITACS…) 60% 40% 20% PUBLIC FUNDING MEDTEQ MEDTEQ TRL 1-3 TRL 7-9 TRL 4-6 Make prototype and prove Validation in relevant Tests in a real clinical concept environment environment and adoption FSISSS MEDTEQ MARKET CECR IDEA COLLABORATIVE DEVELOPMENT VALIDATION, ADOPTION
Project submission process HBHL’S APPROVAL MEDTEQ’S APPROVAL RESEARCH AGREEMENT INITIAL CONTACT STRUCTURING THE PROJECT MEDTEQ will: Assessment of the project Assessment of the executive Signature of the Research projet@medteq.ca statement by: summary by HBHL Strategic Agreement no later than 9 • help identify potential partner(s) sylvie.lau@medteq.ca Steering Committee months after the • MEDTEQ’s Scientific Committee • set-up a work plan confirmation of MEDTEQ’s • Board of Directors • guide you in the writing of financial support. project statement and executive • Final approval by MÉSI summary administration@medteq.ca Confirmation of MEDTEQ financial support MATCHING PUBLIC FUNDS AND INTELLECTUAL PROPERTY • Matching funds from other public funders (e.g. NSERC, MITACS*, etc.). MEDTEQ supports the project team during this step. • Intellectual Property: Discussion between the industrial partner(s) and the Office of Sponsored Research. MEDTEQ does not claim any IP .
CONTACT US SYLVIE LAU Sylvie.lau@medteq.ca 514 398 0896 #2507 WWW.MEDTEQ.CA @medteq_ca
Recommend
More recommend